BRCA2 and prostate carcinoma: Several tumor types, particularly breast, ovarian, pancreatic, and prostate cancer, exhibited a strong correlation between elevated gLOH and biallelic alterations in multiple key HRR genes beyond BRCA1 and BRCA2.